A Prospective Multicenter Randomized Controlled Study on Interleukin-6 Removal and Induction by a new Hemodialyzer With Improved Biocompatibility in Hemodialysis Patients: A Pilot Study

Author:

Kakuta Takatoshi12,Komaba Hirotaka2ORCID,Takagi Nobuyoshi3,Takahashi Yuichiro4,Suzuki Hajime2,Hyodo Toru5,Nagaoka Mikako6,Tanaka Reika7,Iwao Soichiro8,Ishida Mari1,Kobayashi Hiroyuki9,Saito Akira10,Fukagawa Masafumi2

Affiliation:

1. Division of Nephrology, Endocrinology and Metabolism, Department of Medicine; Tokai University Hachioji Hospital; Hachioji Tokyo Japan

2. Division of Nephrology, Endocrinology and Metabolism, Department of Medicine; Tokai University School of Medicine; Isehara Kanagawa Japan

3. Bohsei-Kannai Clinic; Yokohama Kanagawa Japan

4. Jinken Clinic; Ebina Kanagawa Japan

5. Eijin Clinic; Hiratsuka Kanagawa Japan

6. Hon-atsugi Medical Clinic; Atsugi Kanagawa Japan

7. Bohsei-Ohone Clinic; Hadano Japan

8. Chigasaki Central Clinic; Chigasaki Kanagawa Japan

9. Department of Clinical Pharmacology; Tokai University School of Medicine; Kanagawa Japan

10. Tokai University School of Medicine; Isehara Kanagawa Japan

Publisher

Wiley

Subject

Nephrology,Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3